Eisai has been downgraded to "2" by SMBC Nikko.

On the 3rd, SMBC Nikko Securities downgraded the investment rating of Eisai <4523.T> from "1" (the highest of three levels) to "2" (the middle level). The Target Price has been adjusted from 7,000 yen to 4,400 yen. It is expected to take about a year for the growth acceleration of Lecanemab through European launches and subcutaneous formulations.

Kabushiki ShimbunMar 3 23:17 ET

Rating information (investment decision changes - part 1) = Dai Kin, Eisai, ETC.

◎ Daiwa Securities (5 levels: 1 > 2 > 3 > 4 > 5) Daikin <6367.T> -- "3" to "2", 19,000 yen to 19,000 yen ◎ SMBC Nikko Securities (3 levels: 1 > 2 > 3) Eisai <4523.T> -- "1" to "2", 7,000 yen to 4,400 yen ◎ Mizuho Securities (3 levels: Buy > Hold > underperform) Towa Pharmaceutical <4553.T> -- New "Buy", 4,300 yen Sawai Group Holdings <4887.T> -- New "Buy", 3,500 yen NIKON CORP SPONS <7731.T>

Kabushiki ShimbunMar 3 19:50 ET

Rating [Securities company ratings]

Upgraded - Bullish codes Stock name Company Previous Change After --------------------------------------------------------------- <9020> JR East CLSA "Outperform" "High Outperform" <8985> JHR Morgan Stanley "Equal Weight" "Overweight" <6367> Dai Kin Daiwa "3" "2" <6651> Nitto Ko iChiyoshi "B" "A" <3196> Hot Stock Land iChiyoshi "B" "A"

Fisco JapanMar 3 19:13 ET

<Rating Change Observation> Upgraded rating for New and Towa Pharmaceutical / JR East, downgraded rating for Eisai, etc.

◎New and resumed Kansai Electric Power <1942.T> - The domestic mid-sized company has moved up three levels to the highest position. Kinden <1944.T> - The domestic mid-sized company has moved up three levels to the highest position. Towa Pharmaceutical <4553.T> - The bank-affiliated company has moved up three levels to the highest position. Sawai GHD <4887.T> - The bank-affiliated company has moved up three levels to the highest position. Shimadzu <7701.T> - The domestic mid-sized company has moved up five levels to the highest position. ◎Upgraded Hot Stock <3196.T> - The domestic medium-sized company has moved up three levels to the highest position. Daikin <6367.T> - The domestic large company is in the 2nd position of five levels.

Kabushiki ShimbunMar 3 18:51 ET

BioArctic And Eisai's Lecanemab Denied By Therapeutic Goods Administration Of Australia, Delaying Access For Alzheimer's Patients

BenzingaMar 3 04:05 ET

EU Panel Reconfirms Recommendation for BioArctic Partner's Alzheimer's Drug

MT NewswiresFeb 28 10:12 ET